Carbetapentane / diphenhydramine Pregnancy and Breastfeeding Warnings
Brand names: D-Tann AT, Dytan-AT
Carbetapentane / diphenhydramine Pregnancy Warnings
Carbetapentane-diphenhydramine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbetapentane-diphenhydramine is only recommended for use during pregnancy when benefit outweighs risk.
Carbetapentane / diphenhydramine Breastfeeding Warnings
There are no data on the excretion of carbetapentane-diphenhydramine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- (2006) "Product Information. Dytan-AT (carbetapentane-diphenhydramine)." Hawthorn Pharmaceuticals
References for breastfeeding information
- (2006) "Product Information. Dytan-AT (carbetapentane-diphenhydramine)." Hawthorn Pharmaceuticals
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.